Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of Pacritinib and Chemotherapy in Patients With Acute Myeloid Leukemia and FLT3 Mutations

NCT02323607 is registered in ClinicalTrials.gov with Bhavana Bhatnagar as lead sponsor.

NCT NCT02323607
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02323607 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of Pacritinib and Chemotherapy in Patients With Acute Myeloid Leukemia and FLT3 Mutations
Lead sponsor
Bhavana Bhatnagar
Phase
Phase 1
Overall status
Completed
Start date
January 12, 2016
Completion date
July 12, 2018
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent adult acute myeloid leukemia, secondary acute myeloid leukemia, therapy-related acute myeloid leukemia, untreated adult acute myeloid leukemia